Compare SUVEN LIFE with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES FULFORD INDIA SUVEN LIFESCIENCES/
FULFORD INDIA
 
P/E (TTM) x 19.4 398.8 4.9% View Chart
P/BV x 3.9 6.2 63.4% View Chart
Dividend Yield % 0.5 0.1 632.2%  

Financials

 SUVEN LIFESCIENCES   FULFORD INDIA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
FULFORD INDIA
Mar-14
SUVEN LIFESCIENCES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs338942 35.8%   
Low Rs169450 37.6%   
Sales per share (Unadj.) Rs52.1691.4 7.5%  
Earnings per share (Unadj.) Rs6.811.5 59.6%  
Cash flow per share (Unadj.) Rs8.615.4 55.8%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.60.3 205.9%  
Book value per share (Unadj.) Rs65.3380.0 17.2%  
Shares outstanding (eoy) m127.283.90 3,263.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.0 483.2%   
Avg P/E ratio x37.160.7 61.1%  
P/CF ratio (eoy) x29.645.3 65.3%  
Price / Book Value ratio x3.91.8 212.0%  
Dividend payout %22.017.4 125.8%   
Avg Mkt Cap Rs m32,2722,714 1,188.9%   
No. of employees `0001.10.4 243.7%   
Total wages/salary Rs m661505 130.9%   
Avg. sales/employee Rs Th6,132.26,073.0 101.0%   
Avg. wages/employee Rs Th611.11,137.4 53.7%   
Avg. net profit/employee Rs Th803.5100.7 798.1%   
INCOME DATA
Net Sales Rs m6,6352,696 246.1%  
Other income Rs m242125 193.2%   
Total revenues Rs m6,8772,822 243.7%   
Gross profit Rs m1,604-46 -3,457.3%  
Depreciation Rs m22115 1,456.6%   
Interest Rs m3810 396.8%   
Profit before tax Rs m1,58754 2,923.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71810 7,479.1%   
Profit after tax Rs m86945 1,945.0%  
Gross profit margin %24.2-1.7 -1,405.0%  
Effective tax rate %45.217.7 255.8%   
Net profit margin %13.11.7 790.4%  
BALANCE SHEET DATA
Current assets Rs m6,2321,738 358.5%   
Current liabilities Rs m1,490545 273.6%   
Net working cap to sales %71.544.3 161.5%  
Current ratio x4.23.2 131.1%  
Inventory Days Days8648 178.3%  
Debtors Days Days834 1,918.9%  
Net fixed assets Rs m4,04312 33,977.6%   
Share capital Rs m12739 326.4%   
"Free" reserves Rs m8,1831,443 567.1%   
Net worth Rs m8,3101,482 560.7%   
Long term debt Rs m180-   
Total assets Rs m10,3892,077 500.3%  
Interest coverage x43.16.7 641.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.3 49.2%   
Return on assets %8.72.6 334.6%  
Return on equity %10.53.0 346.9%  
Return on capital %19.54.3 453.3%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m5,62217 32,684.7%   
Fx outflow Rs m1,799673 267.3%   
Net fx Rs m3,822-656 -582.7%   
CASH FLOW
From Operations Rs m35690 395.0%  
From Investments Rs m-279105 -266.3%  
From Financial Activity Rs m-225-14 1,596.5%  
Net Cashflow Rs m-148181 -82.1%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 3.8 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 21.2 172.2%  
Shareholders   37,287 4,783 779.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   CADILA HEALTHCARE  TTK HEALTHCARE  PROCTER & GAMBLE HEALTH  DISHMAN PHARMA  J.B.CHEMICALS  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Sep 20, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - TTK HEALTHCARE COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS